Cleerly
Cleerly Raises $106M Series C | AI Heart Disease Detection
Cleerly Closes $106M for Cardiac AI Platform
Cleerly, a digital healthcare company that offers heart disease diagnosis solutions using AI, has raised $106 million in Series C funding.
The round was led by Insight Partners with participation from Battery Ventures and Vensana Capital.
Key Highlights
- Total funding to date: $386.5 million
- AI-powered coronary artery disease detection
- FDA-cleared diagnostic platform
Company Overview
Cleerly has developed an AI-powered cardiac care platform that analyzes heart scans to detect and characterize coronary artery disease with higher accuracy than traditional methods.
Company Info
Investors (3)
Share
Related Reports
Armadin Raises $255.5M Series B for Autonomous Security
Armadin raised a $255.5 million Series B co-led by Andreessen Horowitz and Accel to scale its agentic security platform and its research, training, and go-to-market efforts.
Homeward Raises $120M Series D for Cash Offer and Bridge Financing
Homeward raised a $120 million Series D led by Saluda Grade, plus $330 million in asset-backed debt, to expand cash offer and bridge financing for real estate agents.
Varda Raises $251M Series D for Space-Based Pharmaceutical Processing
Varda Space Industries raised a $251 million Series D led by Lux Capital and Natural Capital to scale space-based pharmaceutical processing.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free